SourceOne Healthcare Technologies and CompuMed Announce Strategic Distribution Agreement
SourceOne will market and distribute CompuMed’s innovative DICOM OsteoGram® software that may be added to existing computed radiography (CR) and digital radiography (DR) systems enabling them to perform bone mineral density screening. This new capability will be introduced at the 90th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago (November 29-December 3)at the SourceOne exhibit (McCormick Place South Building, booth # 1919).
Mentor, OH; Los Angeles, CA (PRWEB) November 18, 2004 -- SourceOne Healthcare
Technologies, Inc., the nation’s leading distributor of medical imaging systems,
equipment, radiographic consumable supplies, and service to healthcare
providers, and CompuMed, Inc., (OTC BB: CMPD.OB), a leading developer of
computer-aided telemedicine and diagnostics technology in the cardiology and
musculoskeletal fields, today announced the companies have signed a new
nationwide distribution agreement.
Under the terms of the agreement,
SourceOne will market and distribute CompuMed’s innovative DICOM OsteoGram®
software that may be added to existing computed radiography (CR) and digital
radiography (DR) systems enabling them to perform bone mineral density screening
for early detection and treatment of osteoporosis. This new capability will be
introduced at the 90th Scientific Assembly and Annual Meeting of the
Radiological Society of North America (RSNA) in Chicago (November 29-December
3). The DICOM OsteoGram® will be on display at the SourceOne exhibit (McCormick
Place South Building, booth # 1919).
This breakthrough second-generation
technology will give SourceOne’s customers the ability to use a simple hand
x-ray to precisely determine bone mineral density (BMD) as an indicator of
osteoporosis and future fracture risk. The hand x-ray film is scanned at the
healthcare provider’s office with a standard desktop scanner, and the Automated
OsteoGram® software analysis program instantly produces a BMD report comparable
to tests performed on the expensive, dedicated BMD testing equipment generally
found in hospitals and specialty practices.
By enabling physicians
everywhere to detect bone loss before fractures actually occur, and intervene
early in the disease stage with available effective treatments, the Automated
OsteoGram can play a major role in reducing the incidence of osteoporosis, one
of the world’s most prevalent and yet preventable diseases.
“One out of
every two women over the age of 50 will experience an osteoporosis-related
fracture in her lifetime,” said Jerry McLaughlin, CompuMed president and CEO.
“Yet many women do not realize that they are at risk for osteoporosis until they
suffer a fracture. Recognizing SourceOne’s excellent national distribution
capabilities, and because the company is truly dedicated to help improving
women’s health, we are excited about the opportunity to provide cutting-edge
women’s health imaging solutions with a new partner that understands our
technology and complements our organization.”
McLaughlin added, “With an
investment that quickly pays for itself, the DICOM OsteoGram® unique add-on
solution, transforms an existing CR or DR system into a bone density measurement
system. This is a perfect fit for SourceOne’s large customer base of women’s
imaging centers, orthopedic offices and hundreds of CR
installations.”
“We are committed to improving women’s health,” said
Jerry C. Cirino, SourceOne president and CEO. “CompuMed’s DICOM OsteoGram® DICOM
enables our customers to provide convenient in-office osteoporosis testing
whereby the patient can be easily and quickly tested anywhere that there is an
installed CR or DR unit. Our national sales and service capabilities, coupled
with a dedicated team of women’s health sales specialists, will enable us to
bring the benefits of CompuMed’s technology to aid in the early detection and
treatment of osteoporosis.”
About SourceOne Healthcare
Technologies
Headquartered in Mentor, Ohio, SourceOne Healthcare Technologies
is a leading provider of imaging equipment and radiographic supplies and
services tailored to healthcare facilities, including those transitioning to a
digital imaging environment. SourceOne offers broad lines of equipment and
consumables as well as e-logistics, sales professionals and field-service
engineers. Our wide offering enables customers to turn to SourceOne as the best
in class source for effective supply chain and medical imaging management.
SourceOne is a privately held company of Platinum Equity, a global acquisitions
firm specializing in the strategic operation of mission-critical companies.
Visit SourceOne at http://www.sourceonehealth.com.
About CompuMed
Founded in 1973, CompuMed, Inc. (CMPD.OB) is a leading provider of
computer-aided telemedicine and diagnostics technology. The company's core
products are the OsteoGram® and CardioGram® systems. The OsteoGram®, which is
cleared by the FDA for commercial use, is an accurate and precise technology for
low-cost osteoporosis testing. The CardioGram® system remotely interprets
electrocardiograms and is used by private practice, government and corporate
healthcare providers nationwide. The CardioGram® has the additional capability
to automatically provide an over-read (i.e., follow-up review) by a
cardiologist. CompuMed is headquartered in Los Angeles. Visit CompuMed at www.compumed.net.
OsteoGram® is a registered trademark of CompuMed, Inc.
CompuMed Safe
Harbor Forward-Looking Statements
This news release contains forward-looking
statements as defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans, objectives,
goals, strategies, future events or performance and underlying assumptions and
other statements that are other than statements of historical facts. These
statements are subject to uncertainties and risks including, but not limited to,
product and service demand and acceptance, changes in technology, ability to
raise capital, availability of appropriate acquisition candidates and/or
business partnerships, economic conditions, impact of competition and pricing,
capacity and supply constraints or difficulties, government regulation and other
risks defined in this document. All such forward-looking statements whether
written or oral, and whether made by or on behalf of the Companies are expressly
qualified by these cautionary statements and any other cautionary statements
which may accompany the forward-looking statements. In addition, the Company
disclaims any obligation to update any forward-looking statements to reflect
events or circumstances after the date hereof.
# # #
Source : http://www.prweb.com/releases/2004/11/prweb179719.htm